You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsDetails

先聲藥業(02096.HK)新冠藥先諾欣於北京首發報價每盒750人幣 股價曾升近8%

阿思達克 01-31 10:06
北京市醫療保障局公布,先聲藥業(02096.HK)新冠治療藥品先諾特韋片/利托那韋片組合包裝先諾欣首發報價為每盒750元人民幣,含稅出廠價格(或進口到岸價格)介乎每盒705至720元人民幣。首發報價對照了奈瑪特韋片/利托那韋片(Paxlovid)、莫諾拉韋膠囊(利卓瑞)以及阿茲夫定片。 先聲藥業今日(31日)早段曾升7.66%高見11.52元,現報10.94元,升2.24%,成交1,910.5萬股,涉資2.14億元。
Relevant Stocks